跳至主要内容
临床试验/NCT07216365
NCT07216365招募中2 期

Caffeine Optimization for Oxygen Saturation Index in ELBW Infants (COFIE Trial)

University of Rochester1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年7月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
40
试验地点
1
主要终点
Total Number of Infant Deaths

研究概览

简要总结

The goal of this clinical trial is to determine whether a higher dose of caffeine citrate can improve breathing and reduce health complications in extremely premature infants, specifically those born before 28 weeks of pregnancy, known as ELGAN infants. These babies often struggle with breathing due to underdeveloped lungs, and caffeine is commonly used to help support their respiratory function. However, the most effective and safest dose has not yet been clearly established.

The study aims to answer two main questions: Does a higher maintenance dose of caffeine (10 mg/kg) lead to better oxygenation, as measured by the Oxygen Saturation Index (OSI), compared to the standard dose (5 mg/kg)? And does the higher dose reduce the risk of serious complications such as lung disease, brain injury, or death-without causing more side effects like fast heart rate, high blood pressure, or poor growth?

To answer these questions, researchers will compare two groups of infants: one receiving the high-dose caffeine treatment and the other receiving the standard dose. This comparison will help determine if the higher dose leads to better outcomes without increased risk.

Participants will begin caffeine treatment once they have regained their birth weight and are at least seven days old. They will be randomly assigned to receive either the high or standard caffeine dose and will be followed until caffeine is stopped or they are discharged from the hospital. During this time, researchers will monitor each infant's oxygenation levels, need for breathing support, signs of common complications, growth and feeding progress, and any side effects. Before discharge, each infant's motor development will also be assessed using a tool called the Test of Infant Motor Performance (TIMP).

This study could help define the most effective caffeine dosing strategy for supporting extremely premature infants and improving their short-term health outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
0 Days 至 27 Weeks(Child)
性别
All
接受健康志愿者
否

入选标准

  • •URMC Inborn Newborn infants born with gestational age of 22 weeks 0 days - 27 weeks 6 days or infants OR ≥ 28 weeks with a birthweight < 1000 grams

排除标准

  • •Hepatic failure, spontaneous intestinal perforation, necrotizing enterocolitis, Anticipated major congenital or genetic anomalies, infants not anticipated to survive beyond 72 hours, infants with mothers that are non-English speaking or <18 years old at time of enrollment.

研究组 & 干预措施

High Dose Caffeine Arm

Experimental

Infants randomized to the high dose caffeine arm will receive an initial standard loading dose of 20 mg/kg caffeine citrate. Beginning at 7 days of life, they will receive a maintenance dose of 10 mg/kg/day caffeine citrate. Dose escalation may be performed at the discretion of the clinical team, with a maximum maintenance dose of 12.5 mg/kg/day if clinically indicated. Caffeine will be administered IV or PO at a 1:1 ratio and prepared in a blinded fashion.

干预措施: Caffeine Citrate (Drug)

Standard Dose Caffeine Arm

Active Comparator

Infants randomized to the standard dose caffeine arm will receive an initial loading dose of 20 mg/kg caffeine citrate. Beginning at 7 days of life, they will receive a maintenance dose of 5 mg/kg/day. Dose escalation may occur at the discretion of the clinical team, with a maximum maintenance dose of 7.5 mg/kg/day. Caffeine will be administered IV or PO at a 1:1 ratio and prepared in a blinded fashion.

干预措施: Caffeine Citrate (Drug)

结局指标

主要结局

Total Number of Infant Deaths

时间窗: From Randomization to 1 year

Number of infants who die before NICU discharge.

Average Oxygen Saturation Index (OSI) per Patient Over First 56 Days

时间窗: From Randomization to Day 56 or Caffeine Discontinuation

The OSI is calculated as (FiO₂ × MAP × 100) / SpO₂. The average OSI per patient will be calculated from randomization through the first 56 days or until caffeine is discontinued or the patient is discharged. Higher OSI values indicate worse oxygenation.

Total Duration of Respiratory Support

时间窗: From Randomization to 1 year

Total number of days each patient receives any respiratory support, including invasive ventilation, CPAP, or supplemental oxygen.

Total Incidence of Severe Bronchopulmonary Dysplasia (BPD)

时间窗: From Randomization to 1 year

Number of infants diagnosed with severe BPD based on NICHD criteria.

Total Incidence of Severe Intraventricular Hemorrhage or Periventricular Leukomalacia (IVH/PVL)

时间窗: From Randomization to 1 year

Number of infants diagnosed with severe IVH (Grade III/IV) or PVL based on cranial imaging.

Total Length of NICU Stay

时间窗: Birth to 1 year

Total number of days each infant remains in the NICU from birth until discharge.

Total Test of Infant Motor Performance (TIMP) Score Prior to Discharge

时间窗: Prior to NICU Discharge

TIMP is a 42-item motor development assessment. Each item scores from 0 to 6. Total scores range from 0 to 252. Higher scores indicate better motor performance.

Total Duration of SpO₂ Below Threshold (Intermittent Hypoxia)

时间窗: From Randomization through Day 56

Cumulative minutes with SpO₂ below target threshold, derived from Neo-DReAMS repository.

Total Time with Heart Rate >180 bpm (Tachycardia)

时间窗: From Randomization to 1 year

Total minutes with heart rate exceeding 180 bpm recorded via monitor.

Total Growth Parameter Z-Scores (Length, Weight, Head Circumference)

时间窗: From Randomization to 1 year

Growth will be assessed using Fenton z-scores. Higher scores reflect better growth relative to gestational norms.

Total Osteopenia Markers (Alkaline Phosphatase, Calcium, Phosphorus)

时间窗: From Randomization to 1 year

Osteopenia assessed by abnormal lab values: alkaline phosphatase \>500 IU/L, abnormal calcium or phosphorus. Abnormal values per infant will be summed.

Total Incidence of Hypertension (>95th Percentile)

时间窗: From Randomization to 1 year

Number of days with blood pressure \>95th percentile for gestational age.

Total Time to Full Enteral Feeds

时间窗: From Randomization to 1 year

Days from birth until the infant reaches 120 mL/kg/day enteral nutrition.

Total Number of NPO Periods >24 Hours

时间窗: From Randomization through NICU Discharge

Number of times infant is NPO (nothing by mouth) for more than 24 hours.

Total Incidence of Necrotizing Enterocolitis (NEC)

时间窗: From Randomization to 1 year

Number of infants diagnosed with NEC (Bell's stage II or higher).

Total Incidence of Spontaneous Intestinal Perforation (SIP)

时间窗: From Randomization to 1 year

Number of infants with radiographically or surgically confirmed SIP.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephanie Vachon

Assistant Professor - Department of Pediatrics

University of Rochester

研究点 (1)

Loading locations...

相似试验